Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Apr. 30, 2018
Apr. 30, 2017
Apr. 30, 2018
Apr. 30, 2017
Revenue $ 750,000 $ 750,000
Operating costs and expenses:        
Inventor royalties, contingent legal fees, litigation and licensing expenses related to patent assertion 500,670 225 526,023 2,346
Amortization of patents 81,324 81,324 162,648 162,648
Research and development expenses (including non-cash stock option compensation expense of $155,769 and $68,928, respectively) 660,193 431,124 1,438,066 882,754
General and administrative expenses (including non-cash stock option compensation expense of $175,941 and $122,991, respectively) 908,767 699,345 1,898,803 1,559,230
Total operating costs and expenses 2,150,954 1,212,018 4,025,540 2,606,978
Loss from operations (1,400,954) (1,212,018) (3,275,540) (2,606,978)
Gain on extinguishment of patent acquisition obligation (Note 6) 1,547,608 1,547,608
Interest expense (175,727) (371,026)
Interest income 8,440 626 17,552 1,625
(Loss) income before income taxes (1,392,514) 160,489 (3,257,988) (1,428,771)
Provision for income taxes
Net (loss) income (1,392,514) 160,489 (3,257,988) (1,428,771)
Less: Net (loss) attributable to noncontrolling interest (13,980) (41,382)
Net loss attributable to common shareholders before deemed dividend (1,378,534) 160,489 (3,216,606) (1,428,771)
Deemed dividend to preferred shareholder (Note 7) (2,008,775)
Net (loss) income attributable to common shareholders $ (1,378,534) $ 160,489 $ (3,216,606) $ (3,437,546)
Net (loss) income per common share attributable to common shareholders:        
Basic (in Dollars per share) $ (0.08) $ 0.02
Diluted (in Dollars per share) (0.08) 0.02
Basic and diluted (in Dollars per share) $ (0.19) $ (0.37)
Weighted average common shares outstanding:        
Basic (in Shares) 16,713,091 9,734,171
Diluted (in Shares) 16,713,091 9,736,571
Basic and diluted (in Shares) 16,661,083 9,236,351